[1]
2021. Incidence of central nervous system metastases in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with trastuzumab: A meta-analysis. Clinics. 76, (Aug. 2021), e2653. DOI:https://doi.org/10.6061/clinics/2021/e2653.